Research comparison
A side-by-side comparison of GHK-Cu and NAD+ as they are characterised in the peer-reviewed research literature. Longevity and cellular ageing research. Both compounds are supplied for in-vitro laboratory research only.
| GHK-Cu | NAD+ | |
|---|---|---|
| Research area | Longevity Research | Longevity Research |
| Sizes stocked | 50mg, 100mg | 100mg, 500mg, 1000mg |
| Reference | Full GHK-Cu page → | Full NAD+ page → |
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II). Characterised in the literature for its high affinity for Cu(II) and its effects in cultured fibroblast models. Supplied as lyophilised powder for in-vitro research use only.
NAD+ (Nicotinamide Adenine Dinucleotide) is a ubiquitous cellular coenzyme characterised in the literature for its role in redox reactions, sirtuin activity and mitochondrial function in preclinical models. Supplied as lyophilised powder for in-vitro research use only.
Both compounds are characterised in the research literature within longevity and cellular ageing research. Researchers typically consult the primary peer-reviewed publications for each compound before selecting one for a specific experimental protocol. The two are frequently studied in parallel and occasionally cited together in comparative pharmacology reviews.
Both GHK-Cu and NAD+ are supplied as lyophilised powder and reconstituted with bacteriostatic water using standard laboratory technique. For full reconstitution methodology see our Research Handling Guide, or compute resulting mg/ml concentrations with the Reconstitution Volume Calculator.
Every batch of both compounds is independently HPLC-verified by Janoshik Analytical at 99%+ purity. The lab report is supplied with every order and carries a unique verification key.